This announcement is a separate document:
大幸薬品：2023年第2四半期の決算の概要
Taiko Pharmaceutical: Summary of Financial Results for the second quarter 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.